Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 25% ± 11% | |
astrocyte | 11 studies | 33% ± 17% | |
oligodendrocyte | 11 studies | 28% ± 12% | |
glutamatergic neuron | 10 studies | 44% ± 27% | |
oligodendrocyte precursor cell | 10 studies | 33% ± 14% | |
fibroblast | 9 studies | 20% ± 4% | |
GABAergic neuron | 8 studies | 45% ± 23% | |
macrophage | 8 studies | 24% ± 6% | |
neuron | 6 studies | 37% ± 14% | |
interneuron | 6 studies | 45% ± 23% | |
microglial cell | 6 studies | 27% ± 7% | |
epithelial cell | 5 studies | 33% ± 11% | |
adipocyte | 5 studies | 20% ± 2% | |
ciliated cell | 5 studies | 23% ± 4% | |
endothelial cell of lymphatic vessel | 5 studies | 21% ± 2% | |
pericyte | 5 studies | 18% ± 3% | |
granule cell | 4 studies | 25% ± 5% | |
amacrine cell | 4 studies | 21% ± 3% | |
retinal rod cell | 4 studies | 21% ± 5% | |
type I pneumocyte | 4 studies | 18% ± 3% | |
monocyte | 4 studies | 20% ± 3% | |
smooth muscle cell | 4 studies | 18% ± 1% | |
hematopoietic precursor cell | 3 studies | 21% ± 5% | |
GABAergic interneuron | 3 studies | 27% ± 5% | |
retina horizontal cell | 3 studies | 18% ± 1% | |
cardiac muscle cell | 3 studies | 18% ± 2% | |
lymphocyte | 3 studies | 21% ± 1% | |
GABAergic amacrine cell | 3 studies | 20% ± 4% | |
glycinergic amacrine cell | 3 studies | 19% ± 3% | |
type II pneumocyte | 3 studies | 19% ± 3% | |
B cell | 3 studies | 21% ± 4% | |
dendritic cell | 3 studies | 23% ± 5% | |
neural progenitor cell | 3 studies | 21% ± 2% | |
alveolar macrophage | 3 studies | 19% ± 5% | |
myofibroblast cell | 3 studies | 18% ± 3% | |
basal cell | 3 studies | 31% ± 4% | |
transit amplifying cell | 3 studies | 26% ± 13% | |
T cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1240.49 | 2642 / 2642 | 100% | 29.97 | 705 / 705 |
esophagus | 100% | 1209.34 | 1445 / 1445 | 100% | 14.66 | 183 / 183 |
prostate | 100% | 1043.71 | 245 / 245 | 100% | 19.67 | 502 / 502 |
uterus | 100% | 1348.01 | 170 / 170 | 100% | 26.62 | 459 / 459 |
breast | 100% | 1146.40 | 459 / 459 | 100% | 24.09 | 1117 / 1118 |
ovary | 100% | 1368.98 | 180 / 180 | 100% | 13.06 | 429 / 430 |
lung | 100% | 1003.28 | 577 / 578 | 100% | 18.43 | 1154 / 1155 |
bladder | 100% | 1294.19 | 21 / 21 | 99% | 19.75 | 501 / 504 |
thymus | 100% | 1031.58 | 653 / 653 | 99% | 22.24 | 601 / 605 |
intestine | 100% | 1251.77 | 966 / 966 | 99% | 18.43 | 522 / 527 |
stomach | 100% | 840.32 | 359 / 359 | 99% | 17.06 | 282 / 286 |
kidney | 100% | 873.42 | 89 / 89 | 99% | 16.49 | 888 / 901 |
adrenal gland | 100% | 1061.14 | 258 / 258 | 98% | 19.60 | 226 / 230 |
pancreas | 97% | 459.75 | 319 / 328 | 100% | 18.13 | 178 / 178 |
skin | 100% | 1389.25 | 1808 / 1809 | 95% | 19.56 | 450 / 472 |
liver | 92% | 372.29 | 209 / 226 | 98% | 11.25 | 396 / 406 |
adipose | 100% | 1134.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1386.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.44 | 29 / 29 |
spleen | 100% | 944.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.92 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.24 | 1 / 1 |
muscle | 100% | 1113.00 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1074.55 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 9.02 | 65 / 80 |
peripheral blood | 74% | 791.02 | 691 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006457 | Biological process | protein folding |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_0016018 | Molecular function | cyclosporin A binding |
Gene name | CWC27 |
Protein name | CWC27 spliceosome associated cyclophilin Spliceosome-associated protein CWC27 homolog (Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog) Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) Spliceosome-associated protein CWC27 homolog (Antigen NY-CO-10) (Probable inactive peptidyl-prolyl cis-trans isomerase CWC27 homolog) (PPIase CWC27) (Serologically defined colon cancer antigen 10) |
Synonyms | hCG_17875 SDCCAG10 UNQ438/PRO871 |
Description | FUNCTION: As part of the spliceosome, plays a role in pre-mRNA splicing . Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity . As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . |
Accessions | A0A8I5KQW2 ENST00000692005.1 ENST00000607786.2 ENST00000693640.1 A0A8I5KUR8 ENST00000688107.1 A0A8I5KZ67 A0A8I5KT14 A0A8I5KXM7 A0A8I5KST0 ENST00000688564.1 ENST00000381070.8 [Q6UX04-1] ENST00000692660.1 ENST00000691921.1 A0A8I5KUW8 ENST00000693303.1 ENST00000688896.1 ENST00000688318.1 A0A8I5KP30 A0A8I5KRH9 A0A8I5KW10 ENST00000685023.1 A0A8I5KRF5 D6REK3 ENST00000693660.1 A0A8I5KP46 ENST00000685234.1 ENST00000692763.1 Q6UX04 ENST00000689574.1 A0A8I5KPF6 A0A8I5KY88 A0A8I5KQK1 ENST00000687314.1 A0A8I5KX65 ENST00000506168.2 A0A8I5KU89 ENST00000508024.2 |